Keith Buechner
Vice President of Investor Relations and FP&A
Replay available
Xylem Inc. (NYSE: XYL) Q3 2025 earnings conference call, held 2025-10-28. Replay captured from the company's public earnings webcast.

Vice President of Investor Relations and FP&A
Chief Executive Officer
Chief Financial Officer
Analyst, Citigroup
Analyst, RBC Capital Markets
Analyst, Melius Research
Analyst, Stifel
Analyst, Barclays
Analyst, BNP Paribas
Analyst, Barrett
Welcome to Xylem's third quarter 2025 results conference call. All participants will be in a listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star, then one on your telephone keypad. To withdraw your question, please press star, then two. Please note that this event is being recorded. I would now like to turn the conference over to Mr. Keith Buechner, Vice President of Investor Relations and FP&A. Please go ahead, sir. Thank you, Operator. Good morning, everyone, and welcome to Xylem's third quarter 2025 earnings call. With me today are Chief Executive Officer Matthew Pine and Chief Financial Officer Bill Grogan. They will provide their perspective on Xylem's third quarter results and discuss the fourth quarter and full year 2025 outlook. Following our prepared remarks, we will address questions related to the information covered on the call. I'll ask that you please keep to one question in a follow-up and then return to the queue. As a reminder, this call and our webcast are accompanied by a slide presentation available in the investor section of our website. A replay of today's call will be available until midnight, November 11th, and will be available for playback via the investor section of our website under the heading investor events. Please turn to slide two. We will make some forward-looking statements on today's call, including references to future events or developments that we anticipate will or may occur in the future. These statements are subject to future risks and uncertainties, such as those factors described in Xylem's most recent annual report on Form 10-K and in sub...